Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation

Molecular and Chemical Neuropathology
L BaumT Saitoh

Abstract

Highly phosphorylated tau protein is the main component of paired helical filaments (PHF), which comprise the neurofibrillary tangles (NFT) in some neurons of patients with Alzheimer disease (AD). Glycogen synthase kinase 3 (GSK3) phosphorylates tau in vitro at several sites also found to be phosphorylated in PHF-tau; tau is phosphorylated at these sites in both AD and normal control (NC) brains, although the extent of phosphorylation is far greater in tau from AD. If GSK3 levels are increased in AD, then tau phosphorylation and perhaps PHF formation may occur. To quantify GSK3, blots of AD and NC brain supernatant and particulate fractions were probed with antibodies to GSK3. In particulate fractions of AD compared to NC, GSK3 alpha immunoreactivity did not increase, but in fact, decreased 40%, and GSK3 beta immunoreactivity decreased 30%. GSK3 alpha and GSK3 beta levels correlated well with each other. GSK3 levels correlated negatively with numbers of NFT.

References

Dec 16, 1992·Biochimica Et Biophysica Acta·S E PlyteJ R Woodgett
Apr 1, 1991·Neuron·D J Selkoe
Jan 22, 1990·Brain Research·D S IimotoT Saitoh
Dec 1, 1993·Trends in Biochemical Sciences·E M Mandelkow, E Mandelkow
Jan 1, 1994·Annual Review of Medicine·D L Price, S S Sisodia
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A TakashimaK Imahori
Nov 1, 1995·Neurobiology of Aging·T OkazakiN Mori

❮ Previous
Next ❯

Citations

Jun 1, 2006·Journal of Neural Transmission·G NiewiadomskaG Riedel
May 4, 2010·Molecular Neurobiology·Sally A Frautschy, Greg M Cole
Oct 24, 2003·FEBS Letters·Baolin LiBinhui Ni
Feb 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chun-Yan WangZhan-You Wang
Feb 1, 2008·The Journal of Biological Chemistry·Margaret H MagdesianSérgio T Ferreira
Oct 22, 2008·Human Molecular Genetics·Shreyasi ChatterjeeGeorge R Jackson
Apr 24, 2010·Human Molecular Genetics·Leslie Crews, Eliezer Masliah
Dec 24, 2010·PloS One·Leonardo M SaraivaFernanda G De Felice
Apr 5, 2012·Neural Plasticity·Wendou Yu, Bingwei Lu
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·X BiG Lynch
Aug 30, 2011·Epilepsy Research·Adam L Hartman
Aug 14, 2003·Biochemical and Biophysical Research Communications·Kenji KikuchiTakeo Kato
Jul 22, 2004·Neuroscience Letters·Roberta BorghiMassimo Tabaton
May 13, 2010·Biochemical and Biophysical Research Communications·Chiaki TanabeShoichi Ishiura
Feb 15, 2015·Journal of Neural Transmission·Jesper RiiseAnna Parachikova
Jun 6, 2012·International Journal of Alzheimer's Disease·Lap HoGiulio Maria Pasinetti
Oct 22, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hei-Man ChowJie Zhang
Aug 29, 2016·Journal of Alzheimer's Disease : JAD·Ravi Rajmohan, P Hemachandra Reddy
Oct 2, 2001·Science's STKE : Signal Transduction Knowledge Environment·J R Woodgett
Nov 6, 2018·Journal of Cellular and Molecular Medicine·Lin-Lin SunShu-Rong Duan
Sep 5, 2020·International Journal of Molecular Sciences·Anna ZmeškalováLenka Maletínská
Jan 31, 2019·Frontiers in Neuroscience·Alireza MajdiAlbert Gjedde
Dec 8, 2020·Frontiers in Cell and Developmental Biology·Francisca Randez-GilJose A Prieto
May 28, 2011·Journal of Chemical Information and Modeling·Jiansong FangJun Xu
Aug 24, 2021·ACS Pharmacology & Translational Science·Ashley C KnightNeil Vasdev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.